CELC - Celcuity Inc.

QQQ $ 435.98 $ 8.58 (2.01 %)

DIA $ 386.87 $ 4.54 (1.19 %)

SPY $ 511.25 $ 6.26 (1.24 %)

TLT $ 89.88 $ 0.90 (1.01 %)

GLD $ 212.97 $ -0.17 (-0.08 %)

Previous Close

$ 17.67

Open

$ 17.78

Bid

$ 0.00 x 0

Ask

$ 0.00 x 0

Day's Range

$ 17.30 - $ 17.78

52 Week Range

$ 8.39 - $ 22.19

Volume

284,562

Average Volume

Market Cap

418.42M

Beta (5Y Monthly)

$ 0.67

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	03-27-2024	12-31-2023	10-K
2	11-13-2023	09-30-2023	10-Q
3	08-11-2023	06-30-2023	10-Q
4	05-15-2023	03-31-2023	10-Q
5	03-23-2023	12-31-2022	10-K
6	11-10-2022	09-30-2022	10-Q
7	08-12-2022	06-30-2022	10-Q
8	05-16-2022	03-31-2022	10-Q
9	03-23-2022	12-31-2021	10-K
10	11-09-2021	09-30-2021	10-Q
11	08-11-2021	06-30-2021	10-Q
12	05-10-2021	03-31-2021	10-Q
13	02-16-2021	12-31-2020	10-K
14	11-09-2020	09-30-2020	10-Q
15	08-10-2020	06-30-2020	10-Q
16	05-07-2020	03-31-2020	10-Q
17	03-13-2020	12-31-2019	10-K
18	11-07-2019	09-30-2019	10-Q
19	08-08-2019	06-30-2019	10-Q
20	05-07-2019	03-31-2019	10-Q
21	03-01-2019	12-31-2018	10-K
22	11-13-2018	09-30-2018	10-Q
23	08-09-2018	06-30-2018	10-Q
24	05-14-2018	03-31-2018	10-Q
25	03-15-2018	12-31-2017	10-K
26	11-13-2017	09-30-2017	10-Q

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

Needham Reiterates Buy on Celcuity, Mainta...
04/12/2024 10:13:38

Needham analyst Gil Blum reiterates Celcuity (NASDAQ:CELC) with a Buy and maintains $24 price target.

Craig-Hallum Maintains Buy on Celcuity, Ra...
03/28/2024 18:19:04

Craig-Hallum analyst Alexander Nowak maintains Celcuity (NASDAQ:CELC) with a Buy and raises the price target from $20 to $25.

HC Wainwright & Co. Reiterates Buy on Celc...
03/28/2024 10:08:23

HC Wainwright & Co. analyst Swayampakula Ramakanth reiterates Celcuity (NASDAQ:CELC) with a Buy and maintains $27 price ...

Needham Maintains Buy on Celcuity, Raises ...
03/28/2024 09:59:41

Needham analyst Gil Blum maintains Celcuity (NASDAQ:CELC) with a Buy and raises the price target from $23 to $24.

Recap: Celcuity Q4 Earnings
03/27/2024 20:15:09

Celcuity Q4 EPS $(0.61) Beats $(0.73) Esti...
03/27/2024 20:14:52

Celcuity (NASDAQ:CELC) reported quarterly losses of $(0.61) per share which beat the analyst consensus estimate of $(0.73) by 1...

Earnings Scheduled For March 27, 2024
03/27/2024 09:02:44

Companies Reporting Before The Bell • Local Bounti (NYSE:LOCL) is projected to report quarterly loss at $2.41 per share on rev...

Celcuity Earnings Preview
03/26/2024 14:01:03

Celcuity Announces First Patient Dosed In ...
02/22/2024 21:41:23

Celcuity Inc. (NASDAQ:CELC), a clinical-stage biotechnology company developing targeted therapies for oncology, today announced...

Stifel Initiates Coverage On Celcuity with...
02/22/2024 11:11:39

Stifel analyst Bradley Canino initiates coverage on Celcuity (NASDAQ:CELC) with a Buy rating and announces Price Target of $40.

HC Wainwright & Co. Initiates Coverage On ...
12/08/2023 12:14:14

HC Wainwright & Co. analyst Swayampakula Ramakanth initiates coverage on Celcuity (NASDAQ:CELC) with a Buy rating and an...

Celcuity Presents Preclinical Data On Ther...
12/06/2023 13:39:00

Celcuity Inc. (NASDAQ:CELC), a clinical-stage biotechnology company pursuing development of targeted therapies for oncology, to...

Celcuity To Present Preclinical Data For G...
12/01/2023 16:16:20

Celcuity Inc. (NASDAQ:CELC), a clinical-stage biotechnology company pursuing development of targeted therapies for oncology, to...

Celcuity Filed Prospectus For Offering Of ...
11/29/2023 21:38:23

https://www.sec.gov/Archives/edgar/data/1603454/000149315223043070/form424b3.htm

Needham Maintains Buy on Celcuity, Lowers ...
11/13/2023 23:29:16

Needham analyst Gil Blum maintains Celcuity (NASDAQ:CELC) with a Buy and lowers the price target from $25 to $23.

Celcuity Q3 Adjusted EPS $(0.78) Misses $(...
11/13/2023 12:08:59

Celcuity (NASDAQ:CELC) reported quarterly losses of $(0.78) per share which missed the analyst consensus estimate of $(0.68) by...

Earnings Scheduled For November 13, 2023
11/13/2023 11:40:53

Companies Reporting Before The Bell • Sohu.com (NASDAQ:SOHU) is expected to report earnings for its third quarter. • Dixie Gr...

A Preview Of Celcuity's Earnings
11/10/2023 14:01:09

Celcuity Inc. Announces $50M Private Place...
10/18/2023 13:16:53

Celcuity Inc. (NASDAQ:CELC), a clinical-stage biotechnology company pursuing development of targeted therapies for oncology, an...

12-health-care-stocks-moving-in-tuesdays-intraday-session

12 Health Care Stocks Moving In Tuesday's ...
10/17/2023 17:31:01